MedTrace Logo

Effect of Transcranial Static Magnetic Field Stimulation in Fibromyalgia Syndrome

NCT04836325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-06-08

No results posted yet for this study

Summary

The main objective is to know if the transcranial static magnetic field stimulation (tSMS) reduces the perception of pain in patients with fibromyalgia and its effect on health-related quality of life. In addition, it will seek to limit the parameters necessary to achieve efficiency with the technique.

Conditions

  • Fibromyalgia

Interventions

PROCEDURE

transcranial static magnetic field stimulation (tSMS)

The intervention group will receive a treatment of tSMS in the primary motor cortex.

PROCEDURE

Sham transcranial static magnetic field stimulation

The placebo group will receive a dummy treatment

Sponsors & Collaborators

  • University of Seville

    lead OTHER

Principal Investigators

  • JOSE-JESUS JIMENEZ-REJANO, PhD · University of Seville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2021-10-31
Completion
2021-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04836325 on ClinicalTrials.gov